The drug by the DRDO has been approved as an adjunct therapy in the moderate to severe COVID-19 cases.
from Jagran Josh https://ift.tt/2Q3rdpJ
via IFTTT
The drug by the DRDO has been approved as an adjunct therapy in the moderate to severe COVID-19 cases.
0 Comments